What's in Abdelwahed, Mai Mahmoud Mohamed, M.D.'s pipeline?

Abdelwahed, Mai Mahmoud Mohamed, M.D. has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Abdelwahed, Mai Mahmoud Mohamed, M.D.'s portfolio?

Top competitors by shared drug class: Cardiochirurgia E.H., Clinica Fabia Mater, GlaxoSmithKline, Hatem AbuHashim, Hospital Universitari Vall d'Hebron Research Institute.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/abdelwahed-mai-mahmoud-mohamed-m-d.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Abdelwahed, Mai Mahmoud Mohamed, M.D. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Abdelwahed, Mai Mahmoud Mohamed, M.D. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
F (ferrous sulphate)	F (ferrous sulphate)	marketed	Iron supplement	Iron (Fe2+) for hemoglobin and myoglobin synthesis	Hematology

Therapeutic area mix

Hematology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Cardiochirurgia E.H. · 1 shared drug class
Clinica Fabia Mater · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Hatem AbuHashim · 1 shared drug class
Hospital Universitari Vall d'Hebron Research Institute · 1 shared drug class
Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri · 1 shared drug class
Laboratoire Innotech International · 1 shared drug class
All India Institute of Medical Sciences · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Abdelwahed, Mai Mahmoud Mohamed, M.D.:

Cite this brief

Drug Landscape (2026). Abdelwahed, Mai Mahmoud Mohamed, M.D. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/abdelwahed-mai-mahmoud-mohamed-m-d. Accessed 2026-05-18.